Weifa AS-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Weifa AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013203
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Weifa AS (Weifa), a subsidiary of Weifa ASA, is a healthcare solution provider that research, develops, produces, distributes and sells medicines, and lifestyle products. The company’s products comprise Tylenol, paracetduo, ibux, ibux gel, tiger balm, proxan, nazareth, dexyl, tussin, bronkyl, pyrisept, codfish, pyrivir cold sore gel, weifa-kalcium dietary supplement, weifa-c rose hip extract, fluormax, ferromax and samin. Weifa produces active pharmaceutical ingredients and finished products. The company operates in Germany, the UK, Eastern Europe, Africa, North America, South America and Asia. Weifa is headquartered in Oslo, Norway.

Weifa AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Weifa AS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Weifa AS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Weifa AS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Weifa AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Weifa AS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Weifa AS, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Weifa Raises USD18 Million in Private Placement of Shares 10
Weifa to Raise USD16.3 Million in Rights Offering of Shares 11
Acquisition 12
Aqualis Completes Acquisition of Weifa for USD183.6 Million 12
Weifa AS – Key Competitors 13
Weifa AS – Key Employees 14
Weifa AS – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Weifa AS, Pharmaceuticals & Healthcare, Key Facts 2
Weifa AS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Weifa AS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Weifa AS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Weifa AS, Deals By Therapy Area, 2011 to YTD 2017 8
Weifa AS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Weifa Raises USD18 Million in Private Placement of Shares 10
Weifa to Raise USD16.3 Million in Rights Offering of Shares 11
Aqualis Completes Acquisition of Weifa for USD183.6 Million 12
Weifa AS, Key Competitors 13
Weifa AS, Key Employees 14

★海外企業調査レポート[Weifa AS-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shamrock Foods Company:企業の戦略的SWOT分析
    Shamrock Foods Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Perilya Limited:企業の戦略・SWOT・財務情報
    Perilya Limited - Strategy, SWOT and Corporate Finance Report Summary Perilya Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • POSCO ICT Company Ltd. (022100):企業の財務・戦略的SWOT分析
    POSCO ICT Company Ltd. (022100) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • General Re Corporation:企業の戦略・SWOT・財務分析
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Biomatlante SA:企業の製品パイプライン分析
    Summary Biomatlante SA (Biomatlante) operates as a biologics solutions provider that manufactures, develops, and commercializes synthetic bone graft technologies and synthetic biomaterials for bone regeneration. The company’s products include inserts, granules, sticks, wedges, syringes, putty, screw …
  • comdirect bank AG:企業の戦略・SWOT・財務情報
    comdirect bank AG - Strategy, SWOT and Corporate Finance Report Summary comdirect bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Astellas Pharma Inc (4503):企業の財務・戦略的SWOT分析
    Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • La Jolla Pharmaceutical Company (LJPC):企業の財務・戦略的SWOT分析
    La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Seaboard Corporation:企業の戦略・SWOT・財務情報
    Seaboard Corporation - Strategy, SWOT and Corporate Finance Report Summary Seaboard Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Manz AG (M5Z):企業の財務・戦略的SWOT分析
    Manz AG (M5Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Fresnillo Plc:企業の戦略・SWOT・財務情報
    Fresnillo Plc - Strategy, SWOT and Corporate Finance Report Summary Fresnillo Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Hartz Mountain Corporation:企業の戦略・SWOT・財務分析
    The Hartz Mountain Corporation - Strategy, SWOT and Corporate Finance Report Summary The Hartz Mountain Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Biocept Inc (BIOC):企業の製品パイプライン分析2018
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Spectra Energy Partners, LP (SEP)-石油・ガス分野:企業M&A・提携分析
    Summary Spectra Energy Partners, LP (Spectra Energy), a subsidiary of Enbridge Inc., is master limited partnership operating in mid-stream energy. The company conducts transmission, storage and gathering of natural gas. It also carries out the transportation and storage of crude oil, and the transpo …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) operates as a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testoster …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hindustan Oil Exploration Co Ltd (HINDOILEXP):企業の財務・戦略的SWOT分析
    Summary Hindustan Oil Exploration Co Ltd (HOEC) is an oil and gas exploration and development company. The company’s business activities include exploration and development of hydrocarbons crude oil and natural gas. It offers geological and geophysical services related to the exploration of oil and …
  • Sanofi India Ltd (SANOFI):企業の財務・戦略的SWOT分析
    Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company. It manufactures and markets pharmaceutical and prescription products. The company offers products in the form of capsules, tablets, injection, vials, ampoules, ointments, creams and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆